Fatigue in fibromyalgia: A conceptual model informed by patient interviews

BMC Musculoskeletal Disorders

Volumn 11, Issue , 2010, Pages

  Humphrey, Louise ^a   Arbuckle, Rob ^a   Mease, Philip ^b   Williams, David A ^c   Samsoe, Bente Danneskiold ^d   Gilbert, Claire ^e  

^a ADELPHI REAL WORLD   (United Kingdom)

^b Seattle Rhumatology Associates   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d FREDERIKSBERG HOSPITAL   (Denmark)

^e PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; INTERVIEW; MALE; REST; SLEEP; WEAKNESS; CHRONIC FATIGUE SYNDROME; COMORBIDITY; METHODOLOGY; MIDDLE AGED; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL;

ADULT; AGED; COMORBIDITY; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; MODELS, PSYCHOLOGICAL;

EID: 77956625804     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-11-216     Document Type: Article

References (40)

1. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. F Wolfe HA Smythe MB Yunus RM Bennett C Bombardier DL Goldenberg, Arthritis Rheum 1990 33 160 172 10.1002/art.1780330203 2306288
2. [Fibromyalgia]. WH Jackel E Genth, Z Rheumatol 2007 66 579 590 10.1007/s00393-007-0229-6 17960398
3. Classification, epidemiology, and natural history of fibromyalgia. KP White M Harth, Curr Pain Headache Rep 2001 5 320 329 10.1007/s11916-001-0021-2 11403735
4. The prevalence and characteristics of fibromyalgia in the general population. F Wolfe K Ross J Anderson IJ Russell L Herbert, Arthritis Rheum 1995 38 19 28 10.1002/art.1780380104 7818567
5. Prevalence of Fibromyalgia: A Survey in Five European Countries. JC Branco B Bannwarth I Failde CJ Abello F Blotman M Spaeth, et al. Semin Arthritis Rheum 2010 39 6 448 453 10.1016/j.semarthrit.2008.12.003 19250656
6. [Rheumatism epidemiology in Europe]. H Raspe, Soz Praventivmed 1992 37 168 178 10.1007/BF01624572 1414018
7. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. L Carmona J Ballina R Gabriel A Laffon, Ann Rheum Dis 2001 60 1040 1045 10.1136/ard.60.11.1040 11602475
8. Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study. F Salaffi R De Angelis W Grassi, Clin Exp Rheumatol 2005 23 819 828 16396700
9. Chronic widespread musculoskeletal pain - a comparison of those who meet criteria for fibromyalgia and those who do not. L Coster S Kendall B Gerdle C Henriksson KG Henriksson A Bengtsson, Eur J Pain 2008 12 600 610 10.1016/j.ejpain.2007.10.001 18024204
10. Gender differences in fibromyalgia and other related syndromes. MB Yunus, J Gend Specif Med 2002 5 42 47 11974674
11. Patient perspectives on the impact of fibromyalgia. LM Arnold LJ Crofford PJ Mease SM Burgess SC Palmer L Abetz, et al. Patient Educ Couns 2008 73 114 120 10.1016/j.pec.2008.06.005 18640807
12. Identifying the Clinical Domains of Fibromyalgia: Contributions From Clinician and Patient Delphi Exercises. PJ Mease LM Arnold LJ Crofford DA Williams IJ Russell LJ Humphrey, et al. Arthritis Rheum 2008 59 952 960 10.1002/art.23826 18576290
13. Fibromyalgia syndrome. P Mease LM Arnold R Bennett A Boonen D Buskila S Carville, et al. J Rheumatol 2007 34 1415 1425 17552068
14. Individuals' descriptions of living with fibromyalgia. MM Cunningham C Jillings, Clin Nurs Res 2006 15 258 273 10.1177/1054773806291853 17056769
15. A phenomenological study of fibromyalgia. Patient perspectives. O Hellstrom J Bullington G Karlsson P Lindqvist B Mattsson, Scand J Prim Health Care 1999 17 11 16 10.1080/028134399750002827 10229986
16. Ten rural women living with fibromyalgia tell it like it is. SA Cudney MR Butler C Weinert T Sullivan, Holist Nurs Pract 2002 16 35 45 11913226
17. The lived experience of fibromyalgia in African American women. KM Schaefer, Holist Nurs Pract 2005 19 17 25 15736726
18. The experience of living with fibromyalgia: confronting an invisible disability. M Sturge-Jacobs, Res Theory Nurs Pract 2002 16 19 31 10.1891/rtnp.16.1.19.52994 12371466
19. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. US FDA Draft Guidance for Industry, 2009 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM193282.pdf
20. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. EMEA/CHMP/EWP/139391/2004. Committee for Medicinal Products for Human Use (CHMP), 2005
21. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial [erratum in J Rheumatol. 2009;36:661]. PJ Mease DJ Clauw RM Gendreau, J Rheumatol 2009 36 398 409 10.3899/jrheum.080734 19132781
22. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. LJ Crofford MC Rowbotham PJ Mease IJ Russell RH Dworkin AE Corbin, et al. Arthritis Rheum 2005 52 1264 1273 10.1002/art.20983 15818684
23. A 14-week, randomized, doubleblinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. LM Arnold IJ Russell E Diri, J Pain 2008 9 792 805 10.1016/j.jpain.2008.03.013 18524684
24. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. P Mease IJ Russell LM Arnold, J Rheumatol 2008 35 502 514 18278830
25. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month double-blind, placebo-controlled trial with pregabalin. LJ Crofford PJ Mease SL Simpson, Pain 2008 136 419 431 10.1016/j.pain.2008.02.027 18400400
26. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia. LM Arnold LJ Crofford SA Martin, Pain Med 2007 8 633 638 10.1111/j.1526-4637.2007. 00332.x 18028041
27. Histological abnormalities in muscle from patients with certain types of fibrositis. EM Bartels B Danneskiold-Samsoe, Lancet 1986 8484 755 757 10.1016/S0140-6736(86)91779-4
28. PA Field JA Morse, Nursing Research: The Application of Qualitative Research London: Croom Held 1985
29. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. C Pope N Mays, BMJ 1995 311 42 45 7613329
30. Grounded Theory and Sensitizing Concepts. GA Bowen, International Journal of Qualitative Methods 2006 5 1 9
31. The constant comparative methods of qualitative analysis. B Glaser AL Strauss, Discovery of Grounded Theory New York: Aldine de Gruyter 1967 101 116
32. BG Glaser AL Strauss, The Discovery of Grounded Theory New York: Aldine 1967
33. AL Strauss J Corbin, Basics of Qualitative research techniques and Procedures for Developing Grounded Theory USA: Sage 1998
34. How many interviews are enough? An experiment with data saturation and variability. G Guest A Bunce L Johnson, Field Methods 2006 18 59 82 10.1177/1525822X05279903
35. Distinguishing fatigue and depression in patients with cancer. PB Jacobsen KA Donovan MA Weitzner, Semin Clin Neuropsychiatry 2003 8 229 240 14613050
36. Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment. NK Leidy M Vernon, Pharmacoeconomics 2008 26 363 370 10.2165/00019053-200826050-00002 18429654
37. Patient-reported outcomes to support medical product labeling claims: FDA perspective. DL Patrick LB Burke JH Powers JA Scott EP Rock S Dawisha, et al. Value Health 2007 10 Suppl 2 125 S137 10.1111/j.1524-4733.2007.00275.x 17995471
38. The prevalence and meaning of fatigue in rheumatic disease. F Wolfe DJ Hawley K Wilson, J Rheumatol 1996 23 1407 1417 8856621
39. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. RC Lawrence CG Helmick FC Arnett RA Deyo DT Felson EH Giannini, et al. Arthritis Rheum 1998 41 778 799 10.1002/1529- 0131(199805)41:5<778::AID-ART4>3.0.CO;2-V 9588729
40. Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability. EA Walker D Keegan G Gardner M Sullivan WJ Katon D Bernstein, Psychosom Med 1997 59 565 571 9407573